These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3958963)

  • 1. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
    Voigt M; Wang RY; Westfall TC
    J Pharmacol Exp Ther; 1986 Apr; 237(1):147-53. PubMed ID: 3958963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
    Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
    Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
    Voigt MM; Wang RY; Westfall TC
    J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Physiol; 2004 Feb; 555(Pt 1):71-84. PubMed ID: 14673185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY; White FJ
    Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
    Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
    J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S; Coleman FH; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of CCK-8S on GABA-induced depolarization from rat dorsal root ganglion.
    Ma KT; Si JQ; Zhang ZQ; Zhao L; Fan P; Jin JL; Li XZ; Zhu L
    Brain Res; 2006 Nov; 1121(1):66-75. PubMed ID: 17055464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
    Wang Y; Perng SL; Lin JC; Tsao WL
    Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CA1 region of the rat hippocampal slice.
    Miller KK; Lupica CR
    J Pharmacol Exp Ther; 1994 Feb; 268(2):753-61. PubMed ID: 8113987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cholecystokinin potentiate dopamine action in the nucleus accumbens?
    Wang RY; Hu XT
    Brain Res; 1986 Aug; 380(2):363-7. PubMed ID: 3756487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic acetylcholine receptors in the anterior, but not posterior, ventral tegmental area mediate ethanol-induced elevation of accumbal dopamine levels.
    Ericson M; Löf E; Stomberg R; Chau P; Söderpalm B
    J Pharmacol Exp Ther; 2008 Jul; 326(1):76-82. PubMed ID: 18369179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.